1. Central subject of the document set [4]

This document set is not about gout [4]. The central subject is: How to provide integrated outpatient care for patients with complex chronic multimorbidity — when international guidelines have WHAT but lack HOW and DATA-to-operate [4]?

Gout is the starting point — the pathology from which Viện Gút began building the model, accumulating data, and forming the operational framework through 18 years of clinical practice [5]. International guidelines — EULAR, ACR, KDIGO, ESC, EASL — all know the WHAT: treatment targets, effective medications, monitoring indices [5]. But no guideline describes the HOW to coordinate multiple guidelines simultaneously for a patient with 4–7 severe diseases at once, in an outpatient setting, over many years [5]. That HOW and DATA-to-operate gap is the central subject of the document set [5].

2. Why gout is the first typical case [6]

Among severe chronic diseases, gout has a unique characteristic that no other disease has: the ultimate treatment target — total dissipation of urate crystals (crystal-free) — can be directly verified by imaging at the time of assessment, without needing indirect inference via biomarkers [6].

• Crystal-free treatment target: the physical structure (urate crystals) completely disappears — different from functional targets (HbA1c, eGFR, EF, Child-Pugh) of other diseases [6].
• Verification tools OMERACT Ultrasound (caliper mm²) and DECT: visualize crystal deposition before treatment and dissipation after treatment [6].
• Closed-loop verification: treatment indication → longitudinal monitoring → confirmation of crystal-free via imaging — a methodological condition for the model to self-validate [7].
• Real-world patients: Severe complicated gout = multimorbidity patients (CKD G3–G5, heart failure, liver cirrhosis, diabetes, GIAI) — gout is just one of the component diseases [7].

“It is not because gout is more important than other diseases, but because gout allows for the most explicit and objective verification of results — a methodological condition for the model to self-validate before expanding to the other three targets [7].”

3. Four verification targets on target organs [8]

After 18 years of clinical practice, a natural structure converged: the four most severe disease axes — gout, kidney, cardiovascular, liver — all have target organ damage measurable by standardized means [8]:

Code [8]	Verification Target [8]	Verification Method [8]
C.1 [8]	Crystal-free [8]	Ultrasound caliper mm² and/or DECT. 155 patients achieved crystal-free (07/2024–01/2026) [8].
C.2 [8]	Renal preservation [8]	eGFR, creatinine, albuminuria time series. Delaying dialysis for CKD G4–G5 [8].
C.3 [8]	Reduced cardiac decompensation [8]	BNP/NT-proBNP, EF, hospitalization frequency. Maintaining stable EF [8].
C.4 [9]	Liver cirrhosis re-compensation [9]	Child-Pugh, MELD, FibroScan, albumin time series. Returning to compensated state [9].

*These four targets are not four targets of gout — they are four targets of four independent severe chronic diseases, co-present in one patient group, managed simultaneously within an integrated outpatient model [9].

4. Verification targets and enabling conditions — two different levels [9]

Not every pathology is an independent verification target [9]. Clinical practice naturally separates into two levels [9]:

Level 1 — Verification Targets (C.1–C.4): Four diseases with specific target organ damage, measurable by imaging or standardized function, which can recover or stabilize when the model operates correctly [9, 10].

Level 2 — Enabling conditions: Pathologies managed not to achieve an independent target — but to keep the window of opportunity for the four verification targets from closing [10]:

Enabling condition [10]	Role in the model [10]
Diabetes [10]	Controlling HbA1c to avoid worsening CKD, heart failure, liver cirrhosis — enabling for all 4 axes [10].
Hypertension [10]	Renal protection, reduced cardiac afterload — enabling for C.2 and C.3 [10].
Lipid disorder [11]	Management of overall cardiovascular risk — enabling for C.3 [11].
GIAI (adrenal insufficiency) [11]	Risk of sudden multi-organ decompensation during physiological stress — special enabling [11].
Anemia, malnutrition [11]	Maintaining a health status safe enough for treatment — foundational enabling for all [11].

5. Why the model was built in outpatient care [11]

In inpatient care, the HOW gap is obscured by layers of concentrated resources: on-site multidisciplinary consultations, continuous monitoring, nursing staff on duty, 24/7 emergency response [11]. When the patient leaves the hospital, all of these disappear — the HOW gap emerges fully intact [11].

Precisely because outpatient care lacks those obscuring resources, the HOW must be designed explicitly from the start: who decides what, when, based on which data, with what feedback SLA, and when to activate referral safety valves [12]. This is why the outpatient model can be systematized and transferred — whereas inpatient HOW is often hidden within the team culture [12].

The Viện Gút model was built in LMIC outpatient conditions from the start — not adjusted down from a large hospital model [12]. Requirements: basic ultrasound, standardized tests, and structured HOW — feasible at any LMIC outpatient facility meeting minimum requirements [12].

6. Five parts of the document set [13]

Part [13]	Content [13]
A — Foundation [13]	A.0: Architectural Statement (this document). A.1: WHAT–HOW–DATA EBM Framework. A.2: Foundational Concepts. A.3: Global HOW Gap. A.4: Operational Concepts. A.5: Standardized Glossary [13].
B — Operation [13]	B.1: First Examination. B.2: Outpatient Treatment Plan. B.3: Window of Opportunity Conditions. B.4: Patient Role. B.5: Enabling conditions and priority principles [13].
C — Verification Targets [13]	C.1: Crystal-free. C.2: Renal preservation. C.3: Reduced cardiac decompensation. C.4: Liver cirrhosis re-compensation. Each document is an invitation for multi-center verification [13].
D — Expansion [14]	D.1: Multi-center verification. D.2: LMIC transfer. D.3: Limitations. D.4: Global system vision [14].
System Architect [14]	Answering the international medical community regarding people, methods, evidence, safety, limitations, and vision [14].

7. Spirit of the document set [14]

The document set is not a claim of having found the final answer [14]. It is the academic systematization of an 18-year practice journey — with full acknowledgement of gaps, limitations, and open questions honestly admitted in Part D [14].

The overarching spirit: The WHAT of international guidelines is fully respected [15]. HOW and DATA-to-operate are results of systematization from practice, built under the coordination of a Clinical Conductor and a multidisciplinary team operating as a sensor–response chain [15]. The four verification targets are an invitation for dialogue and multi-center verification — not a unilateral assertion [15].

8. Position of A.0 in the system [15]

A.0 is the entry point for the entire document set [15]. Experts read A.0 to know: what the document set is about (multimorbidity, not gout), why gout is the starting point, what the four verification targets are, and how the five parts are organized [15]. After A.0: A.1 (EBM framework) → A.2 (definition of three layers) → A.3 (gap evidence) → A.4–A.5 (terminology) → Part B (operation) → Part C (verification targets) [15].